Cargando…
Qianggu capsule for the treatment of primary osteoporosis: evidence from a Chinese patent medicine
BACKGROUND: Qianggu Capsule, a Chinese patent medicine, has been widely applied in the clinical practice of primary osteoporosis (POP) in recent years. This study aims to summarize the effectiveness and safety of Qianggu Capsule in treating POP. METHODS: We searched seven electronic databases, all s...
Autores principales: | Wei, Xu, Xu, Aili, Shen, Hao, Xie, Yanming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5307793/ https://www.ncbi.nlm.nih.gov/pubmed/28193278 http://dx.doi.org/10.1186/s12906-017-1617-3 |
Ejemplares similares
-
Identification of kaempferol as an OSX upregulator by network pharmacology-based analysis of qianggu Capsule for osteoporosis
por: Huang, Ann Yehong, et al.
Publicado: (2022) -
The Evaluation of Xiaozeng Qianggu Tablets for Treating Postmenopausal Osteoporosis via up-Regulated Autophagy
por: Wu, Mingquan, et al.
Publicado: (2022) -
Effects of bushen qianggu method for primary osteoporosis: A protocol for systematic review and meta-analysis
por: Chen, Guocai, et al.
Publicado: (2020) -
Efficacy and safety of Chinese patent medicine (Jinlong capsule) in the treatment of advanced hepatocellular carcinoma: a meta-analysis
por: Xu, He, et al.
Publicado: (2020) -
Chinese patent medicine for osteoporosis: a systematic review and meta-analysis
por: Jia, Yan, et al.
Publicado: (2022)